Oakmark International Strategy Q4 Underperformance Against Benchmark
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Should l Buy UL?
Source: seekingalpha
- Quarterly Performance Review: The Oakmark International Strategy reported a return of 4.93% in Q4, underperforming the MSCI World ex USA Index's gain of 5.20%, indicating relative weakness in the strategy that may affect investor confidence.
- New Investment Positions: During the quarter, the fund initiated positions in AstraZeneca (AZN), IMCD (IMCDY), and Sanofi (SNY), reflecting a strategic focus on biopharmaceuticals and consumer goods to capture future growth potential.
- Position Eliminations: The fund eliminated its holdings in Exor, Komatsu (KMTUY), and Mercedes-Benz Group (MBGAF), indicating a cautious outlook on these companies and a potential strategy to optimize portfolio performance.
- Market Reaction Expectations: Given the underperformance relative to the benchmark, investors may reassess Oakmark's investment strategy, necessitating adjustments to enhance returns and align with market trends.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UL
Wall Street analysts forecast UL stock price to fall
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 73.460
Low
60.10
Averages
68.37
High
74.00
Current: 73.460
Low
60.10
Averages
68.37
High
74.00
About UL
Unilever PLC is a United Kingdom-based global consumer goods business. The Company's segments include Beauty & Wellbeing, Personal Care, Home Care and Foods. The Beauty & Wellbeing segment primarily sells hair care (shampoo, conditioner, styling), skin care (face, hand and body moisturizers) and includes Prestige Beauty and Wellbeing. The Personal Care segment primarily sells skin cleansing (soap, shower), deodorant and oral care (toothpaste, toothbrush, mouthwash) products. The Home Care segment primarily sells fabric care (washing powders and liquids, rinse conditioners) and a range of home and hygiene cleaning products. The Foods segment primarily sells cooking aids and mini-meals (soups, bouillons, seasonings), condiments (mayonnaise, ketchup) and Unilever Food Solutions. The Company's beauty & wellbeing brands include CLEAR, Dermalogica, Liquid I.V., Dove and TRESemme. The Company's home care brands include Cif, Comfort, Domestos, OMO, Radiant, Sunlight and Surf.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Historical AI Use: McCormick has utilized AI in flavor development for nearly a decade, achieving an average reduction in development timelines by 20% to 25% by identifying promising flavor combinations, thereby enhancing product launch speed and market competitiveness.
- Unilever's Innovations: Unilever's systems can digitally test thousands of recipes in seconds, with the Knorr Fast & Flavourful Paste developed in roughly half the usual time, significantly improving R&D efficiency and reducing the need for physical testing.
- Market Potential: Industry analysts estimate that the market for AI in food and beverages will grow from approximately $10 billion in 2025 to over $50 billion by 2030, driven by increased investment in data-driven product development and personalization, indicating substantial business opportunities.
- Importance of Human Creativity: Despite AI's supportive role in food R&D, experts emphasize that human creativity and judgment remain indispensable, with AI serving merely as a tool to enhance the capabilities of R&D teams rather than replacing human sensory evaluation.
See More
- Efficiency Boost in R&D: McCormick has reduced flavor development timelines by 20% to 25% on average through AI, enabling faster identification of promising flavor combinations and accelerating time-to-market for new products.
- Rapid Development at Unilever: Unilever employs AI to digitally test thousands of recipes, resulting in the Knorr Fast & Flavourful Paste being developed in about half the usual time, significantly enhancing product development efficiency and market responsiveness.
- Massive Market Potential: Industry analysts estimate that the market for AI in food and beverages will grow from approximately $10 billion in 2025 to over $50 billion by 2030, reflecting increasing investments in data-driven product development.
- Human Judgment Remains Crucial: Despite AI's significant role in food R&D, experts emphasize that human creativity and judgment are irreplaceable, with AI serving merely as a tool to enhance efficiency and flexibility in the development process.
See More
- Financial Performance: Unilever reported a FY 2023 non-GAAP EPS of €3.08, with turnover at €50.5 billion reflecting a 3.8% year-over-year decline, yet demonstrating stable profitability amid market fluctuations.
- Sales Growth: The company achieved a 3.5% underlying sales growth, with a 1.5% volume increase, indicating its ability to maintain market share in a competitive environment and reflecting the ongoing appeal of its products.
- Margin Expansion: Underlying operating margin expanded to 20.0%, up 60 basis points from the previous year, showcasing the company's success in cost control and operational efficiency, thereby enhancing future profitability sustainability.
- Share Buyback: Unilever announced a €1.5 billion share buyback plan aimed at enhancing shareholder value and boosting market confidence, while projecting 2026 underlying sales growth to remain within the 4% to 6% guidance range despite anticipated market slowdowns.
See More
- Quarterly Performance Review: The Oakmark International Strategy reported a return of 4.93% in Q4, underperforming the MSCI World ex USA Index's gain of 5.20%, indicating relative weakness in the strategy that may affect investor confidence.
- New Investment Positions: During the quarter, the fund initiated positions in AstraZeneca (AZN), IMCD (IMCDY), and Sanofi (SNY), reflecting a strategic focus on biopharmaceuticals and consumer goods to capture future growth potential.
- Position Eliminations: The fund eliminated its holdings in Exor, Komatsu (KMTUY), and Mercedes-Benz Group (MBGAF), indicating a cautious outlook on these companies and a potential strategy to optimize portfolio performance.
- Market Reaction Expectations: Given the underperformance relative to the benchmark, investors may reassess Oakmark's investment strategy, necessitating adjustments to enhance returns and align with market trends.
See More
- Game Outcome: On February 8, 2026, Super Bowl LX saw the Seattle Seahawks defeat the New England Patriots 29-13, with 30 of the 42 total points scored in the fourth quarter, highlighting the game's intensity and enhancing the Seahawks' brand image.
- Ad Performance: According to USA Today's Ad Meter, brands like Anheuser-Busch, Lay's, and Dunkin' resonated well with viewers again this year, indicating effective emotional and comedic messaging strategies that continue to engage audiences.
- Viewer Feedback: Some ads featuring AI tools failed to win over viewers, reflecting a limited acceptance of technology-driven advertising among consumers, suggesting that companies need to reassess their advertising strategies to improve effectiveness.
- Market Impact: The Super Bowl remains a crucial platform for brand marketing, where successful ads can significantly boost brand visibility and directly influence sales performance, prompting companies to increase their advertising budgets in future campaigns.
See More
- IPO Debut Performance: Once Upon a Farm debuted on the NYSE with an opening price of $21 per share, reflecting a 16% increase from its IPO price, and surged 20% in afternoon trading, indicating strong market recognition of its brand.
- Funding Scale and Valuation: The IPO was priced at $18 per share, with approximately 11 million shares sold, raising $197.9 million and valuing the company at $724 million, showcasing investor confidence in the organic children's nutrition market.
- Sales Growth and Financial Status: In 2024, Once Upon a Farm reported net sales of $156.8 million, a 66% increase year-over-year, although losses widened from $17.6 million to $23.8 million, still reflecting robust market demand and growth potential.
- Strategic Development Direction: As a public benefit corporation, Once Upon a Farm plans to use IPO proceeds to pay down debt, purchase new equipment, and support corporate operations, aiming to drive systemic change in childhood nutrition, demonstrating a strong commitment to its long-term strategic goals.
See More








